Topcon acquires Henson perimetry products

Article

Leading perimetry screening devices added to company’s portfolio

Topcon Healthcare has acquired the Henson line of perimetry products from Elektron Eye Technology. As part of the acquisition, members of the Elektron staff will transition to Topcon. Product manufacturing will continue to operate from the UK.

Deal terms were not disclosed, but products including Henson 9000 and 7000 are within the range of products being acquired, according to the company.

The optical perimeter, Henson 9000, is used for early glaucoma detection and ongoing monitoring of established loss. Henson 7000 is an affordable, lightweight, mobile perimeter designed to screen for suprathreshold glaucoma in the central field.

“The acquisition of the Henson range of products will provide us with the opportunity to strategically develop this area of the company’s product portfolio,” said Topcon Healthcare Marketing and Product Design Global VP John Trefethen in a statement.

Related: GenSight Biologics reports results of Lumevoq treatment on LHON patients

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Rachelle Lin, OD, MS, FAAO
Paul Karpecki, OD, FAAO
Melissa Barnett, OD, FAAO, FSLS, FBCLA, gave 2 presentations alongside other ODs and MDs at CRU 2025.
Rachelle Lin, OD, MS, FAAO, at CRU Eye Symposium 2025
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
© 2025 MJH Life Sciences

All rights reserved.